Market capitalization | $20.18m |
Enterprise Value | $22.18m |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | negative |
EV/Sales (TTM) EV/Sales | 0.35 |
P/S ratio (TTM) P/S ratio | 0.31 |
P/B ratio (TTM) P/B ratio | 4.75 |
Revenue growth (TTM) Revenue growth | -8.84% |
Revenue (TTM) Revenue | $64.15m |
As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.
2 Analysts have issued a Flora Growth Corp forecast:
2 Analysts have issued a Flora Growth Corp forecast:
Sep '24 |
+/-
%
|
||
Revenue | 64 64 |
9%
9%
|
|
Gross Profit | 2.15 2.15 |
1,032%
1,032%
|
|
EBITDA | -8.58 -8.58 |
12%
12%
|
EBIT (Operating Income) EBIT | -9.43 -9.43 |
25%
25%
|
Net Profit | -18 -18 |
69%
69%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Flora Growth Corp. engages in the production of organic cannabis and pharmaceutical-grade medical products. It operates through the following segments: Cultivation, Processing, and Supplying of Natural, Medicinal-Grade Cannabis Oil and High Quality Cannabis; Over-the-Counter Medical Products and Medical Cannabis Products; Wellbeing Products; and Food and Beverage Products. The company was founded on March 13, 2019 and is headquartered in Toronto, Canada.
Head office | Canada |
CEO | Clifford Starke |
Employees | 108 |
Founded | 2019 |
Website | www.floragrowth.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.